20
Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lamivudine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-044 - Rev 01
This Chemical Type CEP, issued on October 25, 2017, remains in force until August 19, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2217 associated with this CEP further emphasizes